Hungary's leading wine technology company, Cellarius, has recently installed additional Airocide® units to help wineries remain open and protect staff, visitors, and winemaking operations

MOUNT VERNON, NY / ACCESSWIRE / August 10, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that its distributor, Cellarius, has recently installed additional Airocide® units at wineries in Greece and Hungary, to help control mold and microorganisms in winemaking areas and reduce pathogen spread to create safer and cleaner environment for staff and visitors. Airocide® units were not only installed in the winemaking area, but also in offices, visitor centers, and tasting rooms, bringing the total number of Airocide units installed in the two wineries to nearly 100. Since 2015, Cellarius has installedAirocide® systems in more than 100 wineries in Europe.

Airocide® installation at Biblia Chora winery, Greece

Airocide® technology is utilized globally by over 200 well known winemakers. Airocide® eliminates mold spores and airborne microorganisms, which represent one of the biggest threats to a winemaking environment. If mold grows on the wine barrels, it can result in a very costly loss to the winemaker.

Ignác Ruppert, Managing Director, Cellarius, stated, "We believe that wineries and the wine sector in general is fast becoming one of the most successful markets for Airocide® in Europe. From Portugal to Russia, from Germany to Greece more than 100 wineries use the Airocide® system. Wineries have long grappled with the trade-off of high humidity in a cellar versus the significant microbiological risk from the presence of mold. Airocide® is a perfect solution not only in the barrel room, but also to save their most expensive high-end wines during bottle aging, to avoid TCA problems that can lead to cork taint, and most importantly to protect employees and winetasters from harmful airborne pathogens."

"Airocide® has a long established and proven track record protecting some of the most recognized wineries in the world from the harmful effects of spores, mold and airborne microorganisms," said Q Saeed, CEO of Applied UV. "We are excited about the continued growth and utilization of the Airocide® system within the winery industry and pleased that it can serve an important dual purpose - protecting winemaking operations while also creating a safer and cleaner environment for staff and visitors."

Airocide® utilizes NASA optimized photocatalytic oxidation ("PCO") technology wherein air and any contaminants are drawn from the room into the Airocide® unit and channeled into the reaction chamber. UVC activates the proprietary photocatalyst embedded in the reaction chamber, beginning the photocatalytic process. In the reaction chamber, hydroxyl radicals and super-oxide ions are generated and oxidize every organic molecule that comes in contact. The reaction bed is designed to allow the surface-bound radicals nearly three hundred and sixty degrees of exposure for maximum likelihood of collisions with pathogens and other organic material. Millions of hydroxyl radicals converge, combining with the carbon atoms in pathogens (airborne bacteria, mold, fungi, mycotoxins, viruses, allergens) and VOCs, converting the organic material into a harmless vapor and clean, clear air.

Airocide® System

The Airocide® System, originally developed by NASA with assistance from the University of Wisconsin at Madison, is an airborne pathogen killing technology that uses a patented combination of UVC and a proprietary, titanium dioxide based photocatalyst. Listed as an FDA Class II Medical device, the Airocide® technology is clinically proven and field tested to kill/remove/eliminate airborne pathogenic and non-pathogenic microorganisms, allergens, odors and harmful VOCs in a variety of applications and industries including healthcare, hospitality, grocery chains, wineries, commercial real estate, schools, dental offices and homes. Airocide® air purifiers are available at

About Applied UV

Applied UV is focused on the development and acquisition of technology that address infection control in the healthcare, hospitality, commercial and municipal markets. The Company has two wholly owned subsidiaries - SteriLumen, Inc. ("SteriLumen") and Munn Works, LLC ("Munn Works"). SteriLumen's connected platform for Data Driven Disinfection™ applies the power of ultraviolet light (UVC) to destroy pathogens safely, thoroughly, and automatically, addressing the challenge of healthcare-acquired infections ("HAIs"). Targeted for use in facilities that have high customer turnover such as hospitals, hotels, commercial facilities, and other public spaces, the Company's Lumicide™ platform uses UVC LEDs in several patented designs for infection control in and around high-traffic areas, including sinks and restrooms, killing bacteria, viruses, and other pathogens residing on hard surfaces within devices' proximity. The Company's patented in-drain disinfection device, Lumicide Drain, is the only product on the market that addresses this critical pathogen intensive location. SteriLumen's Airocide® products for air purification, developed by NASA and FDA Cleared as class II medical devices, utilize a proprietary photo-catalytic bioconversion technology that draws air into a reaction chamber that converts damaging molds, microorganisms, dangerous pathogens, destructive VOCs and biological gasses into harmless water vapor without producing ozone or other harmful byproducts. Airocide® applications include healthcare, hospitality, grocery chains, wine making facilities, commercial real estate, schools, dental offices, and homes.

For more information about Applied UV, Inc., and its subsidiaries, please visit the following websites:;; and,

Forward-Looking Statements

The information contained herein may contain "forward?looking statements." Forward?looking statements reflect the current view about future events. When used in this press release, the words "anticipate," "believe," "estimate," "expect," "future," "intend," "plan," or the negative of these terms and similar expressions, as they relate to us or our management, identify forward?looking statements. Such statements include, but are not limited to, statements contained in this press release relating to the view of management of Applied UV concerning its business strategy, future operating results and liquidity and capital resources outlook. Forward?looking statements are based on the Company's current expectations and assumptions regarding its business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. The Company's actual results may differ materially from those contemplated by the forward?looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We caution you therefore against relying on any of these forward?looking statements. Factors or events that could cause the Company's actual results to differ may emerge from time to time, and it is not possible for the Company to predict all of them. The Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward?looking statements to conform these statements to actual results.


Applied UV Investor Relations
Kevin McGrath
TraDigital IR

SOURCE: Applied UV, Inc.

View source version on